Bank of New York Mellon Corp
BankPosition in MRVI — Maravai Lifesciences Holdings, Inc.
CIK 1390777
NEW YORK, NY
Position in MRVI
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$972,508
-$115,227 QoQ
Shares Held
343,643
+2.7% QoQ
Ownership
0.133%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 77.4722604563457.ToString("F0")%
Shared 0.ToString("F0")%
None 22.527739543654317.ToString("F0")%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $4,203,649,111 across 269 Biotechnology names. MRVI ranks #171 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,586,427 | $708,403,098 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
765,411 | $591,387,145 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,679,371 | $317,485,079 | |
| 4 | INSM |
INSMED Inc
|
1,262,749 | $206,484,708 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
491,200 | $162,523,337 | |
| 6 | INCY |
Incyte Corp
|
989,709 | $93,151,403 | |
| 7 | TECH |
BIO-TECHNE Corp
|
1,759,119 | $91,931,549 | |
| 8 | MRNA |
Moderna, Inc.
|
1,691,205 | $85,913,207 |
All Filings in MRVI
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $972,508 | 343,643 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,087,735 | 334,688 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $969,777 | 337,902 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $836,820 | 347,229 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $650,284 | 294,247 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $1,718,348 | 315,294 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $3,317,632 | 399,234 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,625,914 | 506,413 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $3,375,165 | 389,293 | Shares | Other | 2024-04-25 | |
| 2023-12-31 | $2,677,585 | 408,792 | Shares | Other | 2024-01-29 | |
| 2023-09-30 | $5,151,230 | 515,123 | Shares | Other | 2023-10-24 | |
| 2023-06-30 | $6,283,749 | 505,531 | Shares | Other | 2023-08-03 | |
| 2023-03-31 | $8,479,536 | 605,249 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $8,561,642 | 598,298 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $14,071,519 | 551,176 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $16,720,333 | 588,537 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $14,694,078 | 416,617 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $17,190,646 | 410,278 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $17,703,939 | 360,716 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $11,411,568 | 273,462 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $5,760,492 | 161,630 | Shares | Defined | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||